Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 7
2022 21
2023 16
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, Graichen L, Moldenhauer AS, Dopfer-Jablonka A, Stankov MV, Simon-Loriere E, Schulz SR, Jäck HM, Čičin-Šain L, Behrens GMN, Drosten C, Hoffmann M, Pöhlmann S. Zhang L, et al. Among authors: dopfer jablonka a. Cell. 2024 Feb 1;187(3):596-608.e17. doi: 10.1016/j.cell.2023.12.025. Epub 2024 Jan 8. Cell. 2024. PMID: 38194966
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz SR, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Zhang L, et al. Among authors: dopfer jablonka a. Lancet Infect Dis. 2023 Oct;23(10):e391-e392. doi: 10.1016/S1473-3099(23)00547-9. Epub 2023 Sep 13. Lancet Infect Dis. 2023. PMID: 37716358 No abstract available.
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.
Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz SR, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Nehlmeier I, et al. Among authors: dopfer jablonka a. Cell Mol Immunol. 2023 Aug;20(8):969-971. doi: 10.1038/s41423-023-01030-z. Epub 2023 May 8. Cell Mol Immunol. 2023. PMID: 37156807 Free PMC article. No abstract available.
Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life.
Beyer S, Haufe S, Meike D, Scharbau M, Lampe V, Dopfer-Jablonka A, Tegtbur U, Pink I, Drick N, Kerling A. Beyer S, et al. Among authors: dopfer jablonka a. PLoS One. 2023 Oct 23;18(10):e0292928. doi: 10.1371/journal.pone.0292928. eCollection 2023. PLoS One. 2023. PMID: 37870989 Free PMC article.
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.
Stankov MV, Hoffmann M, Gutierrez Jauregui R, Cossmann A, Morillas Ramos G, Graalmann T, Winter EJ, Friedrichsen M, Ravens I, Ilievska T, Ristenpart J, Schimrock A, Willenzon S, Ahrenstorf G, Witte T, Förster R, Kempf A, Pöhlmann S, Hammerschmidt SI, Dopfer-Jablonka A, Behrens GMN. Stankov MV, et al. Among authors: dopfer jablonka a. Lancet Infect Dis. 2024 Jan;24(1):e1-e3. doi: 10.1016/S1473-3099(23)00690-4. Epub 2023 Nov 20. Lancet Infect Dis. 2024. PMID: 37995739 No abstract available.
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3.
Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, Manger B, Baier E, Tampe B, Moerer O, Dickel S, Dopfer-Jablonka A, Jäck HM, Behrens GMN, Winkler MS, Pöhlmann S, Hoffmann M. Arora P, et al. Among authors: dopfer jablonka a. Lancet Infect Dis. 2022 Jun;22(6):766-767. doi: 10.1016/S1473-3099(22)00224-9. Epub 2022 Apr 12. Lancet Infect Dis. 2022. PMID: 35427493 Free PMC article. No abstract available.
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.
Arora P, Kempf A, Nehlmeier I, Graichen L, Schulz S, Cossmann A, Dopfer-Jablonka A, Winkler MS, Jäck HM, Behrens GMN, Pöhlmann S, Hoffmann M. Arora P, et al. Among authors: dopfer jablonka a. Cell Mol Immunol. 2022 Sep;19(9):1067-1069. doi: 10.1038/s41423-022-00870-5. Epub 2022 May 17. Cell Mol Immunol. 2022. PMID: 35581351 Free PMC article. No abstract available.
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.
Behrens GMN, Barros-Martins J, Cossmann A, Ramos GM, Stankov MV, Odak I, Dopfer-Jablonka A, Hetzel L, Köhler M, Patzer G, Binz C, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Krähling V, Bernhardt G, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Hammerschmidt SI, Förster R. Behrens GMN, et al. Among authors: dopfer jablonka a. Nat Commun. 2022 Aug 18;13(1):4872. doi: 10.1038/s41467-022-32527-2. Nat Commun. 2022. PMID: 35982040 Free PMC article.
Effects of Pre-Existing Mental Conditions on Fatigue and Psychological Symptoms Post-COVID-19.
Homann S, Mikuteit M, Niewolik J, Behrens GMN, Stölting A, Müller F, Schröder D, Heinemann S, Müllenmeister C, El-Sayed I, Happle C, Steffens S, Dopfer-Jablonka A. Homann S, et al. Among authors: dopfer jablonka a. Int J Environ Res Public Health. 2022 Aug 11;19(16):9924. doi: 10.3390/ijerph19169924. Int J Environ Res Public Health. 2022. PMID: 36011559 Free PMC article.
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
Odak I, Riemann L, Sandrock I, Cossmann A, Ramos GM, Hammerschmidt SI, Ritter C, Friedrichsen M, Hassan A, Dopfer-Jablonka A, Stankov MV, Weskamm LM, Addo MM, Ravens I, Willenzon S, Schimrock A, Ristenpart J, Janssen A, Barros-Martins J, Hansen G, Falk C, Behrens GMN, Förster R. Odak I, et al. Among authors: dopfer jablonka a. EBioMedicine. 2024 Jan;99:104947. doi: 10.1016/j.ebiom.2023.104947. Epub 2023 Dec 30. EBioMedicine. 2024. PMID: 38160529 Free PMC article.
47 results